Stocktoria
EUPRAXIA PHARMACEUTICALS INC. EPRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-09
EUPRAXIA PHARMACEUTICALS INC. statistics & valuation
Market cap$595.8M
P / B7.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -44.8% | -73.0% | -139.3% | -96.7% |
| Return on equity | -47.0% | -76.3% | -1273.4% | -237.5% |
| Current ratio | 15.12 | 11.10 | 1.02 | 6.08 |
Source: SEC EDGAR filings · CIK 0001581178 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.